Uploaded November 2026 | Updated November 2026, 3 days ago
The FDA announced a new warning on GLP-1 weight loss drugs, cautioning about a rare risk of vision loss connected to decreased blood flow to the optic nerve.
The FDA announced a new warning on GLP-1 weight loss drugs, cautioning about a rare risk of vision loss connected to decreased blood flow to the optic nerve.










